Home > Drug Search >
  • company_query: Ascentage Pharma
  •   > 
Drug Filter
Category:
chemistry (27) biology (2)
Status:
Approved (1) NDA Filing (1) Phase Ⅲ (5) Phase Ⅱ (16) Phase Ⅰ (6)
Clinical Stage:
Pending (4) Active (17) Discontinued (7)
Bio-Type:
Recombinant cytokines (1) Whole antibody (1)
Indication:
Acne (3) Alzheimer's disease (AD) (2) Atopic dermatitis (1) Benign prostatic hypertrophy (1) Breast cancer (5) Chronic lymphocytic leukemia (CLL) (1) Endometrial cancer (1) Glaucoma (1) Glioblastoma multiforme (1) Hypercholesterolemia (1) Lung cancer (1) Lymphoma (5) Malignancies (1) Multiple myeloma (MM) (2) Non small cell lung cancer (NSCLC) (3) Ocular hypertension (1) Ovarian cancer (2) Prostate cancer (1) Psoriasis (1) Small cell lung cancer (SCLC) (1) Soft tissue sarcoma (1) Solid tumours (9) Reperfusion injury (1) Head and neck cancer (1) Colorectal cancer (1) Cervical carcinoma (1) Sarcoma (2) Spinal cord injury (1) Ischemic stroke (1) Ewing's Sarcoma (1) Plaque psoriasis (1) Traumatic brain injury (1) Vasomotor symptoms (1) Myocardia ischemia (1) Congenital lactic acidosis (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top